Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) Return on Equity (2018 - 2025)

Historic Return on Equity for Catheter Precision (VTAK) over the last 8 years, with Q3 2025 value amounting to 2.83%.

  • Catheter Precision's Return on Equity fell 19700.0% to 2.83% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.83%, marking a year-over-year decrease of 19700.0%. This contributed to the annual value of 1.01% for FY2024, which is 36200.0% up from last year.
  • Per Catheter Precision's latest filing, its Return on Equity stood at 2.83% for Q3 2025, which was down 19700.0% from 2.88% recorded in Q2 2025.
  • Catheter Precision's Return on Equity's 5-year high stood at 0.12% during Q4 2021, with a 5-year trough of 3.89% in Q1 2023.
  • Its 5-year average for Return on Equity is 1.56%, with a median of 1.35% in 2024.
  • As far as peak fluctuations go, Catheter Precision's Return on Equity plummeted by -37000bps in 2023, and later soared by 35500bps in 2024.
  • Quarter analysis of 5 years shows Catheter Precision's Return on Equity stood at 0.12% in 2021, then tumbled by -2084bps to 2.47% in 2022, then tumbled by -33bps to 3.28% in 2023, then surged by 59bps to 1.35% in 2024, then tumbled by -109bps to 2.83% in 2025.
  • Its Return on Equity was 2.83% in Q3 2025, compared to 2.88% in Q2 2025 and 1.83% in Q1 2025.